Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting ...
This photo provided by Scotty Ray Boyd shows an overturned truck which had been transporting several monkeys, Tuesday, Oct.
The Jasper Economic Development Corporation Board will meet on Thursday at 5:30 p.m. with a very lengthy agenda.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback